Class IIReported 2025-09-10

Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy

Reason for Recall

Subpotent Drug

Recall Number

D-0609-2025

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2025-07-09

Reported

2025-09-10

Distribution

U.S. Nationwide

Code Info

03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.